Sana Biotechnology, Inc.: cashflow_financing

Value{"amount": 652000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2022-01-01 – 2022-03-31
Statuscurrent
EntitySana Biotechnology, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-22-019299 · Open the official SEC filing →
Retrieved: 2026-08-19T17:57:40.760595+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001770121/cashflow-financing/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f05fdd2d-4487-45fa-89b1-e9c1e1905fc7

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies